Supporting the National Action Plan: Implementing Effective Interventions to Combat MDR-TB

February 11, 2016 - 3:00pm - 5:30pm
Venue: 
FHI 360 Conference Center - Vista Room | 1825 Connecticut Ave NW, 8th Floor, Washington, DC 20009

Panel and reception event.
Light refreshments wil be served.

The White House recently launched the National Action Plan for Combating Multidrug-Resistant Tuberculosis (MDR-TB) which aims to treat 35 percent of all MDR-TB patients in the 10 countries with the highest TB burden by 2018. TB has caused more deaths than any other single infectious disease worldwide. Over the past 20 years the number of people who develop TB has declined annually, but the development and spread of MDR-TB can easily erode and reverse this significant progress. MDR-TB is resistant to the two most potent TB drugs and treatment is significantly more expensive; it presents a major challenge to the health system and pushes people into poverty.

This panel and reception event will delve deeper into some of the specifics of tackling MDR-TB in high-burden environments, with a focus on the successful implementation of proven strategies. Join us as we discuss what is working, what lessons can be learned and applied in other settings, the challenges that remain, and innovative ways to tackle them.

RSVP NOW

 


Join the conversation on Twitter using and follow MSH's policy handle, .


WELCOME:

  • Joanne Carter, Executive Director, RESULTS

PANEL:

  • Muluken Melese Aseresa, Project Director, HEAL TB Project, Ethiopia
  • Alexander Golubkov, Senior Tuberculosis Advisor (MDR-TB), USAID
  • Kenneth Mutesasira, Deputy Project Director, TRACK TB Project, Uganda

MODERATED BY:

  • Josh Michaud, Associate Director, Global Health Policy, Kaiser Family Foundation

 

Printer Friendly VersionPDF